Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Eur J Cardiothorac Surg. 2017 Nov 1;52(5):958-962. doi: 10.1093/ejcts/ezx222.
The pattern of lymph node metastasis is a predominant element in tumour biology, which is closely related to optimal therapeutic modality. Controversy remains as to which histopathology type of oesophageal cancer-adenocarcinoma or squamous cell carcinoma (SCC)-is more likely to have lymph node metastasis. Therefore, this study aimed to apply propensity score-matched analysis to draw an objective conclusion for providing initial evidence of the potential need for different therapeutic strategies for these 2 cancer types.
A retrospective analysis of patients who underwent radical oesophagectomy with lymphadenectomy, but without preoperative treatment for pathologically and immunohistochemically diagnosed oesophageal adenocarcinoma or SCC, was conducted. Data for analysis included age, gender, body mass index, pathologic findings, procedures of oesophagectomy and rate of lymph node metastasis. Propensity score-matched analysis was conducted to eliminate the bias effects of confounding factors.
A total of 1204 patients (including 118 with adenocarcinoma and 1086 with SCC) from January 2012 to June 2016 was included for analysis. In the analysis of unmatched patients, those with adenocarcinomas had significantly larger mean numbers of positive lymph nodes (3.8 and 1.5, respectively; P < 0.001) and higher rates of lymph node metastasis (71.2% and 49.0%, respectively; P < 0.001) than those with an SCC. However, other confounding factors such as surgical procedures, tumour location, pT stage and lymphovascular invasion also differed significantly between the adenocarcinoma and SCC cases. In the analysis of 96 matched patients, those confounding factors were well matched, and cases of adenocarcinoma still had a significantly larger mean number of positive lymph node (4.5 and 1.8, respectively; P = 0.003) and higher rate of lymph node metastasis (75.0% and 45.8%, respectively; P = 0.003) than did those with SCC.
Cases of oesophageal adenocarcinoma had a higher risk of lymph node metastasis than did those with SCC in this series, which indicates that different therapeutic modalities should be applied for these 2 different malignant entities.
淋巴结转移模式是肿瘤生物学中的一个主要因素,它与最佳治疗方式密切相关。关于哪种食管癌——腺癌或鳞状细胞癌(SCC)——更有可能发生淋巴结转移,仍然存在争议。因此,本研究旨在应用倾向评分匹配分析得出客观结论,为这两种癌症类型提供不同治疗策略的潜在需求提供初步证据。
对接受根治性食管切除术和淋巴结清扫术但未经术前治疗的病理和免疫组织化学诊断为食管腺癌或 SCC 的患者进行回顾性分析。分析数据包括年龄、性别、体重指数、病理发现、食管切除术程序和淋巴结转移率。进行倾向评分匹配分析以消除混杂因素的偏倚影响。
共纳入 2012 年 1 月至 2016 年 6 月的 1204 例患者(包括 118 例腺癌和 1086 例 SCC)进行分析。在未匹配患者的分析中,腺癌患者的阳性淋巴结平均数量(分别为 3.8 和 1.5,P<0.001)和淋巴结转移率(分别为 71.2%和 49.0%,P<0.001)明显高于 SCC 患者。然而,其他混杂因素,如手术程序、肿瘤位置、pT 分期和血管淋巴管侵犯,在腺癌和 SCC 病例之间也有显著差异。在 96 例匹配患者的分析中,这些混杂因素得到了很好的匹配,腺癌患者的阳性淋巴结平均数量(分别为 4.5 和 1.8,P=0.003)和淋巴结转移率(分别为 75.0%和 45.8%,P=0.003)仍明显高于 SCC 患者。
在本系列中,食管腺癌的淋巴结转移风险高于 SCC,这表明这两种不同的恶性实体应采用不同的治疗方式。